Skip to main content
Cellid Co., Ltd. logo

Cellid Co., Ltd. — Investor Relations & Filings

Ticker · 299660 ISIN · KR7299660001 KO Manufacturing
Filings indexed 393 across all filing types
Latest filing 2024-02-14 Director's Dealing
Country KR South Korea
Listing KO 299660

About Cellid Co., Ltd.

http://www.cellid.co.kr

Cellid Co., Ltd. is a research and development biotechnology company focused on immunotherapeutic vaccines. The company's activities are centered on two proprietary technology platforms: CeliVax for anti-cancer immunotherapy and an adenovirus vector platform for infectious disease vaccines. The CeliVax platform is used to develop personalized vaccines that utilize a patient's own B cells and monocytes to target specific cancer antigens. The adenovirus vector platform enables the rapid development of safe, non-replicating viral vector vaccines, with a key application being its COVID-19 vaccine candidate. Cellid's pipeline is built upon these core technologies to address unmet medical needs in oncology and virology.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an executive (Kang Chang-yul) of Cellid Co., Ltd. This type of filing is a standard regulatory requirement for reporting insider transactions (director's dealings) in South Korea. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2024-02-14 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the shareholding changes of an executive (Kang Chang-yul) of Cellid Co., Ltd. due to market purchases. This type of filing is specifically categorized as a 'Director's Dealing' (DIRS) as it reports insider transactions by company leadership.
2024-02-13 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (specifically '장내매수' or open market purchase) by an executive (Kang Chang-yul) of the company Cellid. This is a standard regulatory filing for insider trading/director dealings in the Korean market, which corresponds to the 'Director's Dealing' category.
2024-02-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities (Financial Supervisory Service/KRX). It details share acquisitions by a director (Kang Chang-yul) of Cellid Co., Ltd. This type of filing is a standard regulatory disclosure for insider trading/director dealings, which corresponds to the 'Director's Dealing' (DIRS) category.
2024-02-02 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (Cellid) regarding a 'Correction Report' (정정신고) for a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It details amendments to contract terms, such as contract duration and payment schedules for a clinical trial supply agreement. Since this is a specific regulatory disclosure regarding a material contract update and does not fit into the other specialized categories like M&A or financial reports, it is classified as a general regulatory filing.
2024-02-01 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by Cellid Co., Ltd. It details share acquisitions (장내매수) by the CEO, Kang Chang-yul. This type of filing, which reports personal share transactions by company directors and executives, is classified as 'Director's Dealing' (DIRS).
2024-01-29 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.